GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of PCVX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Vaxcyte, Inc. stock upgraded from Sell Candidate to Hold/Accumulate after Friday trading session.
(Updated on Apr 19, 2024)

Hold candidate since Apr 19, 2024 PDF

The Vaxcyte, Inc. stock price gained 0.346% on the last trading day (Friday, 19th Apr 2024), rising from $60.62 to $60.83. During the last trading day the stock fluctuated 4.26% from a day low at $59.39 to a day high of $61.92. The price has risen in 6 of the last 10 days but is still down by -4.94% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 569 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $73.21 million.

The stock lies in the lower of a wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $60.47 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -10.83% during the next 3 months and, with a 90% probability hold a price between $53.92 and $67.39 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

PCVX Signals & Forecast

There are mixed signals in the stock today. The Vaxcyte, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $62.17 and $66.99. A break-up above any of these levels will issue buy signals. A buy signal was issued from a pivot bottom point on Thursday, April 18, 2024, and so far it has risen 0.346%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for Vaxcyte, Inc. stock

Vaxcyte, Inc. finds support from accumulated volume at $60.62 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $2.53 between high and low, or 4.26%. For the last week, the stock has had daily average volatility of 2.69%.

Our recommended stop-loss: $57.03 (-6.25%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 1 day ago.)

Trading Expectations (PCVX) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Vaxcyte, Inc. to open at $60.71, and during the day (based on 14 day Average True Range), to move between $58.54 and $63.12, which gives a possible trading interval of +/-$2.29 (+/-3.76%) up or down from last closing price. If Vaxcyte, Inc. takes out the full calculated possible swing range there will be an estimated 7.51% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $60.62 (0.35%) than the resistance at $71.42 (17.41%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Vaxcyte, Inc. stock A Buy?

Vaxcyte, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: -0.569 Hold/Accumulate Upgraded

Predicted Opening Price for Vaxcyte, Inc. of Monday, April 22, 2024

Fair opening price April 22, 2024 Current price
$60.71 ( 0.192%) $60.83

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for PCVX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 63.24 3.97 %
R2 62.28 2.38 %
R1 61.68 1.40 %
Current price: 60.83
Support S1 59.75 -1.78 %
S2 59.15 -2.76 %
S3 58.18 -4.35 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 75.53 24.17 %
R2 75.27 23.74 %
R1 71.42 17.41 %
Current price 60.83
Support S1 60.62 -0.345%
S2 0 .
S3 0 .

FAQ

What is the symbol for Vaxcyte, Inc. Stock and on which exchange is it traded?
The symbol for Vaxcyte, Inc. is PCVX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Vaxcyte, Inc. Stock?
Vaxcyte, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

How to buy Vaxcyte, Inc. Stock?
Vaxcyte, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Vaxcyte, Inc. Stock.

What's the current price of Vaxcyte, Inc. Stock?
As of the end of day on the 2024-04-19, the price of an Vaxcyte, Inc. (PCVX) share was $60.83.

What is the 52-week high and low for Vaxcyte, Inc. Stock?
The 52-week high for Vaxcyte, Inc. Stock is $82.04 and the 52-week low is $41.57.

What is the market capitalization of Vaxcyte, Inc. Stock?
As of the 2024-04-19, the market capitalization of Vaxcyte, Inc. is 6.768B.

When is the next earnings date for Vaxcyte, Inc.?
The upcoming earnings date for Vaxcyte, Inc. is May 13, 2024.
Click to get the best stock tips daily for free!

About Vaxcyte, Inc.

Vaxcyte. Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company also develops VAX-XP to protect against emerging strains and address antibiotic resistance; VAX-A1, a co... PCVX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT